VoxCell BioInnovation

This week, we had the distinct pleasure of hosting Christian Barrow, Executive Director - Life Sciences Banking, and Sebastian Kong, Life Sciences Banking, from J.P. Morgan at our facility. It was an incredible opportunity to showcase the groundbreaking work VoxCell BioInnovation is leading in tissue engineering, including the development process behind our vascularized tissue models. We also shared our exciting plans for partnerships with drug developers, highlighting how our vascularized tissue models are revolutionizing drug candidate screening by enabling early identification of viable therapies. We are thrilled to see the growing interest in our innovations and look forward to continuing our mission of advancing healthcare through impactful collaborations. #LifeSciences #Biotech #Innovation #TissueEngineering #Partnerships

Exciting Visit at VoxCell BioInnovation! This week, we had the immense honor of hosting Lakshmi Krishnan, VP of Life Sciences at the National Research Council Canada / Conseil national de recherches Canada), along with members of the NRC team, at our facility. During their visit, we showcased the groundbreaking advancements VoxCell is making in the field of tissue engineering. From demonstrating our proprietary development process to highlighting the creation of vascularized tissue models, it was an incredible opportunity to share how VoxCell is redefining possibilities in drug development and preclinical research. We are deeply grateful for the NRC’s ongoing support and their recognition of our innovative work. #Innovation #TissueEngineering #Bioprinting #LifeSciences #Collaboration

We're thrilled to share that our CEO, Dr. Karolina Valente, will be representing VoxCell BioInnovation at the McCarthy Spotlight Speaking Series tonight. She’ll be presenting VoxCell’s vision, achievements, and plans for the future. We’re honored to be among such innovative companies shaping the future of life sciences in Canada. Join us to celebrate innovation, connect with leaders, and hear from our incredible CEO! #VoxCellBioInnovation #Bioprinting #LSBCSpotlight #LifeSciences #Innovation #Leadership

We are thrilled to share that VoxCell BioInnovation has been selected as a Deep Tech Pioneer by Hello Tomorrow chosen from over 4,600 applications across 120 countries! This recognition highlights the impact of our work in advancing preclinical research with our 3D bioprinted tissue models and Universal Bioinks™. Join us at the 10th Hello Tomorrow Global Summit in March 2025 to connect and celebrate game-changing deep tech innovation. Thank you to Hello Tomorrow for this incredible opportunity—we’re excited to continue pushing the boundaries of biotechnology! #DeepTechPioneer #HelloTomorrow #VoxCellBioInnovation #3DBioprinting #Biotechnology

Join VoxCell BioInnovation at University of Victoria Biomedical Engineering and Health Technology Showcase at the Michele Pujol Room today! Don’t miss our Biomedical Engineer, Annelise Lapointe, presenting VoxCell’s first stage of validation studies on our triple-negative breast cancer tissue model at 11:00 AM PST. In attendance from our team is Asees Kaur, our Business Development and Strategy Specialist, Ekaterina Shteinberg our Tissue Engineering Scientist, and Jenna Sonmor our R&D Engineering Co-op! This is a unique opportunity to learn how VoxCell’s innovative technologies are advancing preclinical oncology research. Come connect with VoxCell—we look forward to seeing you there! #VoxCellBioInnovation #BiomedicalEngineering #TripleNegativeBreastCancer #HealthTech

Honored to represent VoxCell BioInnovation at BDO Canada’s VC Pitch Competition last week! Thrilled that VoxCell was recognized as one of the top 6 startups to pitch to investors. A big thanks to BDO Canada for this opportunity to showcase our innovations in 3D bioprinting and preclinical drug development. Excited for what’s next! #Biotech #Innovation #3DBioprinting #Startup

💡IP Insights: How VoxCell BioInnovation Increased Valuation with a Strong IP Portfolio VoxCell BioInnovation, an AccelerateIP & NVBC Competition alum, is revolutionizing cancer drug testing with their 3D bioprinting technology. Thanks to the AccelerateIP program, they built a robust IP portfolio, which helped them close a critical seed round and accelerate growth. 🔬 “[The AccelerateIP - Stream 3 program] helped us accelerate our IP approach, probably from years to a matter of months. We went from having one and a half patents to having five provisional patents in total.” - Asees Kaur, VoxCell BioInnovation 👉 Read the full story: https://ow.ly/geOL50TIoUm 🔎 Explore more IP Insights on our blog: https://ow.ly/SoBW50TIoUp

Experience the Future of Drug Development at #MicroTAS2024! VoxCell BioInnovation is pushing the boundaries of drug screening with our innovative vascularized human cancer tissue models. 📅 Join us on Wednesday, October 16th at poster w.536.h with our Biomedical Scientist, Sam Paton, to see our proof-of-concept data firsthand for our bioprinted breast cancer models, demonstrated through Paclitaxel, a clinically-approved breast cancer drug. Our Business Development and Strategy Specialist, Asees Kaur, will also be at booth #1, so swing by to chat with us about how we’re transforming oncology research with cutting-edge 3D bioprinting technology. 🔗 Learn more about our work: www.voxcellbio.com 📧 For inquiries, reach us at: hello@voxcellbio.com We’re excited to meet you at #MicroTAS2024 and show how our technology is paving the way for more effective, human-like models in cancer drug testing! #CancerTissueModels #BreastCancerResearch #Bioprinting #3DCellCulture #VascularizedTissues #DrugScreening #PrecisionMedicine

Exciting News! VoxCell BioInnovation is heading to the microTAS 2024 conference in Montreal from October 13-17! Come visit us at Booth #1, where we’ll be showcasing our Universal Bioink Kit, Gelatin Methacryloyl (GelMA), and Methacrylated Hyaluronic Acid (MHA) biopolymers, highlighting their key features compared to commercial alternatives. If you’re an independent researcher or part of a group focused on 3D bioprinting, don’t miss this chance to connect with us! 📅 Poster Presentation – Wednesday, Oct 16: We’ll be presenting our study on our vascularized 3D bioprinted tissue models, with a focus on our breast cancer model. Join us to hear about our latest research! 👥 Attendees from VoxCell: Asees Kaur – Business Development and Strategy Specialist Sam Paton – Biomedical Scientist We’re eager to meet with fellow researchers, scientists, and industry leaders. Let’s discuss how we can collaborate to advance your projects. Come find us at Booth #1 or during our presentation—we’d love to connect! 🔗 Learn more about VoxCell here: https://lnkd.in/dg3UzDc #microTAS2024 #3DBioprinting #TissueModels #Bioinks #VoxCell #BreastCancerResearch #Networking #Innovation

VoxCell is looking for a Lead Mechatronics Engineer. Check out the job posting below or reach out to me directly if you would like to know more.